Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease. - Wikidata - awgldk - TriplyDB

Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.

Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.

http://www.wikidata.org/entity/Q34241396

about

Natriuretic Peptides and Cardiometabolic Health Cardiac biomarkers: new tools for heart failure management Atrial natriuretic peptide in cardiovascular biology and disease (NPPA)Cardiovascular diseases related to ionizing radiation: The risk of low-dose exposure (Review)Novel biomarkers for cardiovascular risk prediction.Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk Risk stratification in emergency patients by copeptin Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease.Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial.Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study.Cardiovascular redox and ox stress proteomics.Plasma COOH-terminal proendothelin-1: a marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29)Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies: Does Utility Depend on Risk Thresholds For Treatment?Combined Framingham Risk Score and Coronary Artery Calcium Score Predict Subclinical Coronary Plaque Assessed by Coronary Computed Tomography Angiogram in Asymptomatic Taiwanese Population.Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation Plasma copeptin levels are inversely associated with intima-media-thickness in men: the population-based KORA F4 study.Neurohormonal Activation After Atrial Fibrillation Initiation in Patients Eligible for Catheter Ablation: A Randomized Controlled Study.Therapeutic implications of biomarkers in chronic heart failure.Natriuretic peptides in cardiovascular diseases: current use and perspectives Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases.Copeptin as a biomarker in heart failure.Molecular and Digital Biomarker Supported Decision Making in Clinical Studies in Cardiovascular Indications.Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial.Estimating covariate-adjusted measures of diagnostic accuracy based on pooled biomarker assessments.Predictive value of plasma copeptin level for the risk and mortality of heart failure: a meta-analysis.Fibrosis as measured by the biomarker, tissue inhibitor metalloproteinase-1, predicts mortality in Age Gene Environment Susceptibility-Reykjavik (AGES-Reykjavik) Study.Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study.Effects of B-type natriuretic peptide on cardiovascular biomarkers in healthy volunteers.Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.

P2860

Q26827702-D2110E3C-6530-4607-A8E8-3123358D5789 Q26991726-33D4F93E-40B2-4521-8AAD-E0AD5E9ED8A1 Q28082833-37901181-01F8-47E5-B5EC-5F29D157D18F Q30244472-597C22C8-7570-41C2-8098-60021DFACB6B Q33615459-A2A44B55-F2EB-46B5-9E9C-DD3507FF8DFF Q33715302-260B91FE-38A7-44E1-BD62-FD9824730CCA Q33740059-43859FCC-749B-45EB-BAB3-09B148756393 Q33765268-EDB9AE95-7D75-4A05-B04E-E1402AE13A8A Q34421217-A425206D-0A86-4F7C-BCB7-6E43429358A4 Q34662255-45257211-96F5-4C06-8453-E7775F2C779F Q36047921-605C92CB-92DB-4C35-8F88-6A235783FFE3 Q36168678-67892634-8F2A-42AD-AF0F-F7509C005DE8 Q36252927-88FEC58E-0A9E-4C7B-B089-60A0FEED7D93 Q36334718-A4FBB4EF-195D-46EF-A10B-CCBCCB9324BC Q36472407-CEC31F78-4566-42FA-824F-204D21F88BA9 Q36721163-1A232BFF-1388-47FA-A83B-0E10A47B081B Q36764895-C5DCB43B-A372-4C07-BD7C-8EACB49AE747 Q37280819-B445EB2F-F0FF-4C32-BF24-16E106C9AA74 Q37306950-4D2F323F-C79F-4008-A503-D084AD4FE67C Q37556419-9758D769-A9DD-4DDB-A594-CB8043EA3B8E Q38121720-299EA6A0-58F2-4D78-A259-0BC67DE5C5D4 Q38162429-695322BB-3C9F-42DF-BE2A-B1CAECA86EE5 Q38194620-B7E39793-E37E-4C9A-8050-35A64B9A91AF Q38249996-8C6D4491-4D26-4994-895E-AF682B5D34B5 Q38815451-4DCD6FEB-6701-46DC-A67B-F93D7966E7E2 Q38838027-3DC10ED5-D73D-4ED2-A506-97947DBF4A35 Q39014581-FED29B1A-53CC-4DF7-9248-57169519765B Q39959126-A5A589DF-12BA-41D4-8F35-83B50DE348F4 Q41520470-57B9F313-D83F-4CF5-B5D2-AD0907E98DAB Q47613602-77038CA6-67BA-4B62-88E1-9A6D9D3822D2 Q47855200-74A42BC0-27DA-49F5-B1BA-49A524E22193 Q48239494-8FC1B85D-902E-455E-9A1F-DD550C4C8CA1 Q48277492-20E846F6-49C9-457A-8924-92CDA6C4F036 Q48400230-3B0E1CE9-A7CB-4DF1-95CF-784B5A3AF6F7 Q51000313-A7183C8C-FEC0-450B-8DF9-75A26BEF4231

P2860

Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.

http://www.wikidata.org/entity/Q34241396

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Evaluation of multiple biomark ...... with stable coronary disease.

@ast

Evaluation of multiple biomark ...... with stable coronary disease.

@en

Evaluation of multiple biomark ...... with stable coronary disease.

@nl

type

label

Evaluation of multiple biomark ...... with stable coronary disease.

@ast

Evaluation of multiple biomark ...... with stable coronary disease.

@en

Evaluation of multiple biomark ...... with stable coronary disease.

@nl

prefLabel

Evaluation of multiple biomark ...... with stable coronary disease.

@ast

Evaluation of multiple biomark ...... with stable coronary disease.

@en

Evaluation of multiple biomark ...... with stable coronary disease.

@nl

P1433

Q34241396-3431C92D-9D94-4136-B54E-55B5A91F1E2C

P1476

Q34241396-EB402923-2BD4-4021-B9A2-A89EA5FBB992

P2093

Q34241396-28010E23-1D7A-4CDE-9D20-EF5B6DC2779B

Q34241396-3E13216B-5BBA-4A33-9085-7F6C43E7D0C9

Q34241396-472186D6-A663-491E-82CD-3547264276AA

Q34241396-796C82D3-7C04-4545-8F73-A3E16CF80736

Q34241396-B165675B-1E41-45CF-A570-CC74B0512EAB

Q34241396-B61E9387-225C-4FEA-8401-2A29EF36EDA4

Q34241396-C5FA1CF5-AB11-483B-94C4-150A89935655

Q34241396-C7AA65D8-4971-4A9D-832F-2AECE1AD2DCF

P2860

Q34241396-0F300077-301D-4202-B8C7-6DB52FAAA214

Q34241396-104C09F8-328B-42CF-B48A-F4BB70722791

Q34241396-21715A8D-656F-48FD-B8D6-A5F996E5E070

Q34241396-2B20C96A-A7BD-4271-87E1-F3690D167DC9

Q34241396-4135169F-425E-42F3-A93E-54B68B3710E6

Q34241396-53A4F3F0-6A6B-4EBC-9250-FCE3370A01B9

Q34241396-5963DE09-C741-4FC5-BE88-0558F3A5F79C

Q34241396-5A1A4C12-00B5-4493-A336-321E9E25968B

Q34241396-5CE35111-D2DC-4020-87B7-8FEFCFD5C45B

Q34241396-747EF60F-628E-492C-82FE-55258408B662

P304

Q34241396-CC26861E-EE2E-4377-A493-BD8D90EB7345

P31

Q34241396-2C2CEC07-61E4-4F43-9344-3A7D2F7D5C7B

P356

Q34241396-C7DD7BD7-B9DB-4A59-92EC-35961D9B793E

P407

Q34241396-28F4C28F-2034-4A96-A1CB-D755D65C981E

P433

Q34241396-EDCD1857-5B98-4FB8-AC76-907F2DCA05E3

P478

Q34241396-06820EF4-9C44-4755-8CAF-61AC2A4D1A02

P50

Q34241396-2DBF5A29-1899-4F5E-96E2-8610969A1125

P577

Q34241396-A154D80B-A13D-45C2-AFB7-C4BDD0D0B606

P5875

Q34241396-C97FB09F-C749-4CA0-9C7C-51EBA47AD5E7

P698

Q34241396-683FDA4B-D884-4BF4-B41D-8A82735A2701

P921

Q34241396-939CD641-0538-4B04-AC9E-6379D72F6207

Q34241396-9AABF429-77D3-4C3F-9D7D-8D25C8D48984

Q34241396-D7A384F9-606A-4CEB-B8B8-39B98FA042F8

P932

Q34241396-5F041F35-55A4-4EB3-868C-0A6D8061ACAD

P356

CIRCULATIONAHA.111.063842

P1433

P1476

Evaluation of multiple biomark ...... with stable coronary disease.

@en

P2093

David A Morrow

http://www.w3.org/2001/XMLSchema#string

James A de Lemos

http://www.w3.org/2001/XMLSchema#string

Marc A Pfeffer

http://www.w3.org/2001/XMLSchema#string

Marc S Sabatine

http://www.w3.org/2001/XMLSchema#string

Petr Jarolim

http://www.w3.org/2001/XMLSchema#string

Sarah Sloan

http://www.w3.org/2001/XMLSchema#string

Scott D Solomon

http://www.w3.org/2001/XMLSchema#string

Torbjorn Omland

http://www.w3.org/2001/XMLSchema#string

P2860

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes

Biomarkers in heart failure

Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1

A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?

Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

The clinical relevance of adrenomedullin: a promising profile?

P304

233-240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.111.063842

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Eugene Braunwald

P577

2011-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51898107

http://www.w3.org/2001/XMLSchema#string

P698

22179538

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

3277287

http://www.w3.org/2001/XMLSchema#string